Lurasidone is an atypical antipsychotic.In the USA since 2013. Lurasidoneis also approved for the treatment of depressive episodes associated with bipolar I disorder (bipolar depression) in adults when used alone or in combination with lithium or valproate.Lurasidoneis FDA approved for the treatment of schizophrenia and depressive episodes associated with bipolar I disorder.
|
Product name
|
(3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione
|
|
CAS
|
14805-29-9
|
|
MF
|
C9H11NO2
|
|
Purity
|
99%
|
|
Product name
|
3-(1-Piperazinyl)-1,2-benzisothiazole
|
|
CAS
|
87691-87-0
|
|
MF
|
C11H13N3S
|
|
Purity
|
99%
|
